Abstract
Aim
Although the role of genetic polymorphisms of leptin receptor (LEPR) gene in several cancers has been documented, the association between polymorphisms of LEPR gene and lung cancer remains unknown.
Method
We recruited 744 patients histologically diagnosed as non-small cell lung cancer (NSCLC) and 832 controls in this study. Polymorphism analysis of LEPR gene was performed by PCR–restriction fragment length polymorphisms.
Results
The Arg/Arg genotype and Arg allele frequency of the Gln223Arg in LEPR gene were significantly prevalent in NSCLC subjects than in controls (P < 0.05). The odd ratio (OR) for NSCLC in Arg/Arg genotype carriers was 3.12 (95% CI: 2.25–4.56, P = 0.0023, with Gln/Gln as reference). There were no significant differences in the genotype distributions and allele frequencies of Lys109Arg and Lys656Asn in LEPR gene between NSCLC cases and controls (All P > 0.05). The Arg/Arg carriers had higher cancer grade and higher TNM stage. Kaplan–Mier curve showed the Arg/Arg carriers had a poor prognosis than those with Gln/Arg and Gln/Gln genotype carriers. Cox proportional hazards regression models showed the hazard ratio (HR) for death associated with Arg/Arg genotype was 3.43 (95% CI: 2.45–5.92, compared with Gln/Gln carriers, P = 0.002). The other two SNPs of LEPR gene did not show this trend in the evaluation of their role in determining the prognosis of NSCLC subjects.
Conclusion
The results suggest the polymorphisms of Gln223Arg, rather than Lys109Arg and Lys656Asn, may be used as a molecular marker for progression and prognosis of NSCLC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aloulou N et al (2008) Involvement of the leptin receptor in the immune response in intestinal cancer. Cancer Res 68(22):9413–9422
Chagnon YC, Chung WK, Pérusse L, Chagnon M, Leibel RL, Bouchard C (1999) Linkages and associations between the leptin receptor (LEPR) gene and human body composition in the Québec Family Study. Int J Obes Relat Metab Disord 23(3):278–286
Dieudonne MN et al (2002) Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 293(1):622–628
Hansel NN et al (2009) Leptin receptor polymorphisms and lung function decline in COPD. Eur Respir J 34(1):103–110
He BS et al (2011) Effect of LEPR Gln223Arg polymorphism on breast cancer risk in different ethnic populations: a meta-analysis. Mol Biol Rep [Epub ahead of print]
Hu X et al (2002) Leptin–a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94(22):1704–1711
Ishikawa M, Kitayama J, Nagawa H (2004) Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10(13):4325–4331
Israel D, Chua S Jr (2010) Leptin receptor modulation of adiposity and fertility. Trends Endocrinol Metab 21(1):10–16
Kim HS (2009) Leptin and leptin receptor expression in breast cancer. Cancer Res Treat 41(3):155–163
Kim Y et al (2006) Effects of the expression of leptin and leptin receptor (OBR) on the prognosis of early-stage breast cancers. Cancer Res Treat 38(3):126–132
Laud K et al (2002) Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 188(1–2):219–226
Li WY, Lai BT, Zhan XP (2004) The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer. Zhonghua Liu Xing Bing Xue Za Zhi 25(12):1042–1045
Lim YJ et al (2005) Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neurosci Lett 374(3):157–160
Marti A et al (2009) Association between leptin receptor (LEPR) and brain-derived neurotrophic factor (BDNF) gene variants and obesity: a case-control study. Nutr Neurosci 12(4):183–188
Okobia MN et al (2008) Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study. BMC Cancer 8:338
Pechlivanis S et al (2009) Genetic variation in adipokine genes and risk of colorectal cancer. Eur J Endocrinol 160(6):933–940
Qian Q et al (2011) Meta analysis of association between Ser326Cys polymorphism of hOGG1 gene and risk of lung cancer. Zhongguo Fei Ai Za Zhi 14(3):205–210
Quinton ND et al (2001) A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. Hum Genet 108(3):233–236
Ribeiro R et al (2006) A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancer. Eur J Cancer 42(8):1188–1193
Suzukawa M et al (2011) Leptin enhances survival and induces migration, degranulation, and cytokine synthesis of human basophils. J Immunol 186(9):5254–5260
Uddin S et al (2009) Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer. Mol Cancer 8:74
Vasku A, Vokurka J, Bienertova-Vasku J (2009) Obesity-related genes variability in Czech patients with sporadic colorectal cancer: preliminary results. Int J Colorectal Dis 24(3):289–294
Yapijakis C et al (2009) Association of leptin -2548G/A and leptin receptor Q223R polymorphisms with increased risk for oral cancer. J Cancer Res Clin Oncol 135(4):603–612
Yuan SS et al (2004) Aberrant expression and possible involvement of the leptin receptor in bladder cancer. Urology 63(2):408–413
Conflict of interest
The authors declare there is no conflict of interest concerning this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, Y., Geng, J., Wang, Y. et al. The role of leptin receptor gene polymorphisms in determining the susceptibility and prognosis of NSCLC in Chinese patients. J Cancer Res Clin Oncol 138, 311–316 (2012). https://doi.org/10.1007/s00432-011-1098-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-011-1098-6